🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 23 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/03/1993 33,69 35,56 33,69 34,62 -2,63% 5,56% 2.298
23/03/1993 37,43 37,43 34,62 35,56 +0,00% 7,50% 3.927
22/03/1993 39,30 39,30 35,56 35,56 -8,43% 9,52% 6.652
19/03/1993 40,24 40,24 37,43 38,83 -3,49% 6,98% 1.469
18/03/1993 40,24 40,24 37,43 40,24 +6,17% 6,98% 1.763
17/03/1993 40,24 40,24 37,43 37,90 -5,81% 6,98% 882
16/03/1993 40,24 40,24 37,43 40,24 +3,61% 6,98% 721
15/03/1993 41,17 41,17 37,43 38,83 -3,49% 9,09% 4.462
12/03/1993 39,30 41,17 39,30 40,24 -2,27% 4,76% 668
11/03/1993 41,17 41,17 39,30 41,17 +2,33% 4,55% 4.088
10/03/1993 42,11 42,11 40,24 40,24 +0,00% 4,44% 4.248
09/03/1993 43,04 43,04 40,24 40,24 -2,27% 6,52% 4.221
08/03/1993 40,24 43,04 37,43 41,17 +6,02% 13,95% 11.835
05/03/1993 38,37 38,83 36,49 38,83 +1,22% 6,10% 38.873
04/03/1993 38,37 38,37 36,49 38,37 +0,00% 4,88% 11.194
03/03/1993 38,37 38,37 36,49 38,37 +0,00% 4,88% 2.244
02/03/1993 38,37 38,37 36,49 38,37 +5,13% 4,88% 802
01/03/1993 38,37 38,37 36,49 36,49 -4,88% 4,88% 1.630
26/02/1993 36,49 38,37 36,49 38,37 +2,50% 5,13% 721
25/02/1993 34,62 38,37 34,62 37,43 -2,44% 10,81% 3.313
24/02/1993 38,37 38,37 36,49 38,37 +2,50% 4,88% 9.378
23/02/1993 38,37 38,37 35,56 37,43 +0,00% 7,32% 10.981
22/02/1993 36,49 39,30 35,56 37,43 +8,11% 10,26% 12.584
19/02/1993 35,56 37,43 33,69 34,62 +5,71% 10,53% 11.515
18/02/1993 33,69 34,62 32,75 32,75 +0,00% 5,56% 9.992
17/02/1993 36,49 36,49 31,82 32,75 -2,78% 12,82% 57.681
16/02/1993 38,37 38,37 33,69 33,69 -7,69% 12,20% 26.476
12/02/1993 36,49 38,37 36,49 36,49 -4,88% 5,13% 214
11/02/1993 38,37 38,37 36,49 38,37 +0,00% 4,88% 668
10/02/1993 38,37 38,37 36,49 38,37 +5,13% 4,88% 989